Synaptic vesicle glycoprotein 2A is a ubiquitous synaptic vesicle protein that in humans is encoded by the SV2A gene.
The protein is targeted by the anti-epileptic drugs (anticonvulsants) levetiracetam and brivaracetam but not the chemically similar drug etiracetam.